Cargando…
Glycosylated Nanoparticles for Cancer-Targeted Drug Delivery
Nanoparticles (NPs) are novel platforms that can carry both cancer-targeting molecules and drugs to avoid severe side effects due to nonspecific drug delivery in standard chemotherapy treatments. Cancer cells are characterized by abnormal membranes, metabolic changes, the presence of lectin receptor...
Autores principales: | Torres-Pérez, Sergio Andrés, Torres-Pérez, Cindy Estefani, Pedraza-Escalona, Martha, Pérez-Tapia, Sonia Mayra, Ramón-Gallegos, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735155/ https://www.ncbi.nlm.nih.gov/pubmed/33330106 http://dx.doi.org/10.3389/fonc.2020.605037 |
Ejemplares similares
-
Phage Display Libraries for Antibody Therapeutic Discovery and Development
por: Almagro, Juan C., et al.
Publicado: (2019) -
Evolution of Anti-SARS-CoV-2 Therapeutic Antibodies
por: Almagro, Juan C., et al.
Publicado: (2022) -
The use of nanoparticles for targeted drug delivery in non-small cell lung cancer
por: Holder, Jessica E., et al.
Publicado: (2023) -
Glycosylation of Glycolipids in Cancer: Basis for Development of Novel Therapeutic Approaches
por: Daniotti, Jose L., et al.
Publicado: (2013) -
CRISPR-dCas9-Based Artificial Transcription Factors to Improve Efficacy of Cancer Treatment With Drug Repurposing: Proposal for Future Research
por: Martinez-Escobar, Alejandro, et al.
Publicado: (2021)